Literature DB >> 6101508

Adrenergic modulation of extrarenal potassium disposal.

R M Rosa, P Silva, J B Young, L Landsberg, R S Brown, J W Rowe, F H Epstein.   

Abstract

We studied the role of catecholamines in the regulation of potassium homeostasis in nine healthy subjects given intravenous potassium chloride (0.5 meq per kilogram of body weight) in the presence and absence of propranolol. Potassium infusion elevated serum potassium 0.6 +/- 0.09 meq per liter (mean +/-S.E.M.). Addition of propranolol augmented the rise (0.9 +/- 0.05 meq per liter) and prolonged the elevation in serum potassium without decreasing urinary potassium excretion. In a separate study, the same potassium load was administered with a concomitant infusion of epinephrine in five subjects. Epinephrine markedly blunted the increment in serum potassium (0.1 +/- 0.06 meq per liter) while reducing renal potassium excretion. Plasma aldosterone was not altered by the experimental procedures. Serum insulin fell minimally in the presence of propranolol but was unaffected by epinephrine. beta-Adrenergic blockade impairs and epinephrine enhances extrarenal disposal of an acute potassium load. These findings suggest that in patients with impaired potassium disposal, the risk of hyperkalemia may be increased when sympathetic blockade is induced.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6101508     DOI: 10.1056/NEJM198002213020803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  32 in total

1.  Hypokalemia in a pediatric patient on continuous renal replacement therapy: Answers.

Authors:  Alexandra Idrovo; Ayse Akcan-Arikan; Rossana Malatesta-Muncher; Leyat Tal
Journal:  Pediatr Nephrol       Date:  2019-12       Impact factor: 3.714

2.  A complication to be aware of: hyperkalaemia following propranolol therapy for an infant with intestinal haemangiomatozis.

Authors:  Burcu Belen; Aynur Oguz; Arzu Okur; Buket Dalgic
Journal:  BMJ Case Rep       Date:  2014-05-19

3.  Beta-blockers, trimethoprim-sulfamethoxazole, and the risk of hyperkalemia requiring hospitalization in the elderly: a nested case-control study.

Authors:  Matthew A Weir; David N Juurlink; Tara Gomes; Muhammad Mamdani; Daniel G Hackam; Arsh K Jain; Amit X Garg
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

Review 4.  Endocrine physiology of electrolyte metabolism.

Authors:  K G Dawson
Journal:  Drugs       Date:  1984-10       Impact factor: 9.546

5.  Potassium tolerance and bronchial reactivity in asthmatic and nonasthmatic atopic subjects.

Authors:  L Marazzini; R Cavestri; B Mastropasqua; M Bozzoni; M Pacetti; E Longhini
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

Review 6.  Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy.

Authors:  Sara S Roscioni; Dick de Zeeuw; Stephan J L Bakker; Hiddo J Lambers Heerspink
Journal:  Nat Rev Nephrol       Date:  2012-10-16       Impact factor: 28.314

Review 7.  Hyperkalemia in patients with heart failure: incidence, prevalence, and management.

Authors:  Akshay S Desai
Journal:  Curr Heart Fail Rep       Date:  2009-12

8.  A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.

Authors:  A Brent Alper; Ruth C Campbell; Stefan D Anker; George Bakris; Christy Wahle; Thomas E Love; L Lee Hamm; Marjan Mujib; Ali Ahmed
Journal:  Int J Cardiol       Date:  2008-08-08       Impact factor: 4.164

Review 9.  Potassium and anaesthesia.

Authors:  J E Tetzlaff; J F O'Hara; M T Walsh
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

10.  Ventricular arrhythmias in patients with myocardial infarction and ischaemia. The role of serum potassium.

Authors:  R J Solomon
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.